Attorney General Pam Bondi defended DOJ actions aggressively while the department faces massive staffing losses, heavy Epstein-file redactions, and low morale.
Chaos at the FDA leaves staffers disturbed, ready to leave
Internal turmoil and leadership controversies at the FDA are driving experienced staff departures and hindering recruitment, threatening regulatory predictability for pharma and biotech.